Hepatitis E epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 18: | Line 18: | ||
==Developed Countries== | ==Developed Countries== | ||
The rate of anti-HEV antibodies is lower than in developing countries. <ref name="pmid23013075">{{cite journal| author=Hoofnagle JH, Nelson KE, Purcell RH| title=Hepatitis E. | journal=N Engl J Med | year= 2012 | volume= 367 | issue= 13 | pages= 1237-44 | pmid=23013075 | doi=10.1056/NEJMra1204512 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23013075 }} </ref> | |||
==Developing Countries== | ==Developing Countries== | ||
Hepatitis E may occur either as a sporadic case, or as an [[epidemic]] disease. It is often caused by [[genotype]]s 1 (Asia) and 2 (Central America and Africa).<ref name="pmid18192058">{{cite journal| author=Purcell RH, Emerson SU| title=Hepatitis E: an emerging awareness of an old disease. | journal=J Hepatol | year= 2008 | volume= 48 | issue= 3 | pages= 494-503 | pmid=18192058 | doi=10.1016/j.jhep.2007.12.008 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18192058 }} </ref> Anti-HEV antibodies were detected in 30 to 80% of adults.<ref name="pmid23013075">{{cite journal| author=Hoofnagle JH, Nelson KE, Purcell RH| title=Hepatitis E. | journal=N Engl J Med | year= 2012 | volume= 367 | issue= 13 | pages= 1237-44 | pmid=23013075 | doi=10.1056/NEJMra1204512 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23013075 }} </ref> | Hepatitis E may occur either as a sporadic case, or as an [[epidemic]] disease. It is often caused by [[genotype]]s 1 (Asia) and 2 (Central America and Africa).<ref name="pmid18192058">{{cite journal| author=Purcell RH, Emerson SU| title=Hepatitis E: an emerging awareness of an old disease. | journal=J Hepatol | year= 2008 | volume= 48 | issue= 3 | pages= 494-503 | pmid=18192058 | doi=10.1016/j.jhep.2007.12.008 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18192058 }} </ref> Anti-HEV antibodies were detected in 30 to 80% of adults.<ref name="pmid23013075">{{cite journal| author=Hoofnagle JH, Nelson KE, Purcell RH| title=Hepatitis E. | journal=N Engl J Med | year= 2012 | volume= 367 | issue= 13 | pages= 1237-44 | pmid=23013075 | doi=10.1056/NEJMra1204512 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23013075 }} </ref> | ||
Revision as of 21:04, 27 August 2014
|
Hepatitis E Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Hepatitis E epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hepatitis E epidemiology and demographics |
|
Risk calculators and risk factors for Hepatitis E epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Prevalence
Incidence
Age
Gender
Pregnant Women
Race
Developed Countries
The rate of anti-HEV antibodies is lower than in developing countries. [1]
Developing Countries
Hepatitis E may occur either as a sporadic case, or as an epidemic disease. It is often caused by genotypes 1 (Asia) and 2 (Central America and Africa).[2] Anti-HEV antibodies were detected in 30 to 80% of adults.[1]
References
- ↑ 1.0 1.1 Hoofnagle JH, Nelson KE, Purcell RH (2012). "Hepatitis E." N Engl J Med. 367 (13): 1237–44. doi:10.1056/NEJMra1204512. PMID 23013075.
- ↑ Purcell RH, Emerson SU (2008). "Hepatitis E: an emerging awareness of an old disease". J Hepatol. 48 (3): 494–503. doi:10.1016/j.jhep.2007.12.008. PMID 18192058.